Does combined clopidogrel-aspirin therapy initiated within 72 hours after stroke onset reduce the risk of new stroke at 90 days in patients with mild ischemic stroke or high-risk TIA of presumed atherosclerotic cause?
Initiating combined clopidogrel-aspirin therapy within 72 hours of a mild ischemic stroke or high-risk TIA reduces the risk of new stroke at 90 days compared to aspirin alone, though with a slight increase in bleeding risk.
Among patients with mild ischemic stroke or high-risk TIA of presumed atherosclerotic cause, combined clopidogrel-aspirin therapy initiated within 72 hours after stroke onset led to a lower risk of new stroke at 90 days than aspirin therapy alone but was associated with a low but higher risk of moderate-to-severe bleeding. (Funded by the National Natural Science Foundation of China and others; INSPIRES ClinicalTrials.gov number, NCT03635749.).
Gao et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: